Cotadutide significantly reduces blood sugar and weight in diabetics with CKD: Study Medha Baranwal29 April 2022 10:45 AM ISTUK: A recent study in the journal Diabetes, Obesity and Metabolism has found that cotadutide is an effective treatment option in patients with...
Oral semaglutide greatly reduces blood sugar and weight in type 2 diabetes patients: Study Medha Baranwal23 April 2022 9:15 AM ISTUSA: Treatment with oral semaglutide in type 2 diabetes patients results in consistently greater HbA1c reduction and weight loss, and more...
Liraglutide and semaglutide reduce MACE in diabetes patients regardless of PAD status: Study Medha Baranwal21 April 2022 9:00 AM ISTDenmark: Liraglutide and semaglutide may reduce major adverse cardiovascular events (MACE) in type 2 diabetes (T2D) patients regardless of their...
Low-carbohydrate diet improves blood sugar, body weight in type 2 diabetes: Study Medha Baranwal28 Feb 2022 10:15 AM ISTDenmark: A recent study in the journal Diabetes, Obesity and Metabolism showed a beneficial effect of a non-calorie-restricted low-carbohydrate...
Imeglimin, a potential new treatment option as add-on to insulin therapy in type 2 diabetes: TIMES 3 trial Medha Baranwal15 Feb 2022 9:15 AM ISTFrance: Recent data from the TIMES-3 trial showed that imeglimin when used as an add-on agent to insulin was effective in reducing blood sugar levels...
Type 2 diabetes: Ultra rapid lispro reduces PP glucose and shows faster pharmacokinetics than Humalog Medha Baranwal23 Nov 2021 10:00 AM ISTUSA: Ultra-rapid lispro (URLi), a novel ultra-rapid mealtime insulin, showed accelerated insulin lispro absorption and greater reduction in...
Empagliflozin reduces insulin initiation in patients with diabetes and CVD: EMPA-REG OUTCOME trial Medha Baranwal25 Oct 2021 9:30 AM ISTUSA: Empagliflozin markedly and durably delays insulin initiation and substantial increases in insulin dose in patients with type 2 diabetes and...
Insulin degludec has lower rates of nocturnal hypoglycaemia in T1D compared to insulin glargine: Study MD Editorial Team22 Oct 2021 11:00 AM ISTNocturnal hypoglycemia is a serious complication of insulin-treated diabetes, which commonly goes undetected. Patients with T1D have lower...
Dapagliflozin, saxagliptin combo bests glimepiride for controlling blood sugar in diabetes: Study Medha Baranwal30 Sept 2021 12:45 PM ISTUSA: The combo of dapagliflozin+saxagliptin+metformin was associated with better blood sugar control, efficacy, and metabolic benefits than...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha Baranwal20 July 2021 11:45 AM ISTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to...
Liraglutide addition to SGLT2 inhibitors intensifies type 2 diabetes treatment: Study Medha Baranwal17 July 2021 12:45 PM ISTDelhi: Liraglutide (1.8 mg) seems to be an effective way to intensify the treatment of type 2 diabetes irrespective of BMI, HbA1c, insulin resistance,...
Bariatric surgery tied to hypoglycemia risk in people without diabetes: Study Medha Baranwal9 Jun 2021 9:30 AM ISTSweden: Bariatric surgery compared to usual care increases the risk of hypoglycemia-related events in patients without diabetes, finds a recent study...
